These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 10690626)
1. Measles IgA in the nasal washings of adult volunteers and children immunized intranasally with measles vaccine L-16. Liashenko VA; Krasnova VP; Youminova NV Hum Antibodies; 1999; 9(3):143-8. PubMed ID: 10690626 [TBL] [Abstract][Full Text] [Related]
2. Mucosal IgA responses in healthy adult volunteers following intranasal spray delivery of a live attenuated measles vaccine. Simon JK; Ramirez K; Cuberos L; Campbell JD; Viret JF; Muñoz A; Lagos R; Levine MM; Pasetti MF Clin Vaccine Immunol; 2011 Mar; 18(3):355-61. PubMed ID: 21228137 [TBL] [Abstract][Full Text] [Related]
3. Oral spray immunization may be an alternative to intranasal vaccine delivery to induce systemic antibodies but not nasal mucosal or cellular immunity. Bakke H; Samdal HH; Holst J; Oftung F; Haugen IL; Kristoffersen AC; Haugan A; Janakova L; Korsvold GE; Krogh G; Andersen EA; Djupesland P; Holand T; Rappuoli R; Haneberg B Scand J Immunol; 2006 Mar; 63(3):223-31. PubMed ID: 16499576 [TBL] [Abstract][Full Text] [Related]
4. Persistence of immunity against measles in persons immunized with Edmonston-Zagreb vaccine. abu Eldan J; Borćić B; Smerdel S Acta Med Croatica; 1991; 45(4-5):297-304. PubMed ID: 1726513 [TBL] [Abstract][Full Text] [Related]
5. [A trial of the intranasal vaccination of adults against measles: the approaches to an alternative revaccination method]. Liashenko VA; Iuminova NV; Krasnova VP Vopr Virusol; 1992; 37(2):107-9. PubMed ID: 1441428 [TBL] [Abstract][Full Text] [Related]
6. A long-term follow-up study on the efficacy of further attenuated live measles vaccine, Biken CAM vaccine. Isomura S; Morishima T; Nishikawa K; Hanada N; Rahman M; Terashima M; Kido S; Ueda S; Takahashi M Biken J; 1986 Mar; 29(1):19-26. PubMed ID: 3778422 [TBL] [Abstract][Full Text] [Related]
8. Immunologic studies of specific mucosal and systemic immune responses in Mexican school children after booster aerosol or subcutaneous immunization with measles vaccine. Bellanti JA; Zeligs BJ; Mendez-Inocencio J; García-Garcia ML; Islas-Romero R; Omidvar B; Omidvar J; Kim G; Fernandez De Castro J; Sepulveda Amor J; Walls L; Bellini WJ; Valdespino-Gomez JL Vaccine; 2004 Mar; 22(9-10):1214-20. PubMed ID: 15003650 [TBL] [Abstract][Full Text] [Related]
9. Mucosal adenovirus-vectored vaccine for measles. Lobanova LM; Baig TT; Tikoo SK; Zakhartchouk AN Vaccine; 2010 Nov; 28(48):7613-9. PubMed ID: 20887832 [TBL] [Abstract][Full Text] [Related]
10. [Unsuitability of children revaccination against measles]. Bolotovskiĭ VM; Titova NS Sov Med; 1981; (9):43-8. PubMed ID: 7313794 [No Abstract] [Full Text] [Related]
11. [Measurement of the in vitro immune response of live attenuated measles virus vaccine and antibody levels in 0 to 10-year-old children]. Unalan H; Ustaçelebi S Mikrobiyol Bul; 1985 Oct; 19(4):218-28. PubMed ID: 3831724 [TBL] [Abstract][Full Text] [Related]
12. Aerosolized measles and measles-rubella vaccines induce better measles antibody booster responses than injected vaccines: randomized trials in Mexican schoolchildren. Bennett JV; Fernandez de Castro J; Valdespino-Gomez JL; Garcia-Garcia Mde L; Islas-Romero R; Echaniz-Aviles G; Jimenez-Corona A; Sepulveda-Amor J Bull World Health Organ; 2002; 80(10):806-12. PubMed ID: 12471401 [TBL] [Abstract][Full Text] [Related]
13. [Studies on the persistence of immunity 14-15 years after vaccination with a live measles vaccine]. Zhonghua Yi Xue Za Zhi; 1989 Jul; 69(7):389-91. PubMed ID: 2598095 [No Abstract] [Full Text] [Related]
14. [Intranasal revaccination of children with live measles vaccine: development of local immunity]. Liashenko VA; Iuminova NV; Krasnova VP; Glazkova NV; Svirina VS Vopr Virusol; 1999; 44(3):124-6. PubMed ID: 10392436 [TBL] [Abstract][Full Text] [Related]
15. Immunogenicity of aerosol measles vaccine given as the primary measles immunization to nine-month-old Mexican children. Wong-Chew RM; Islas-Romero R; García-García Mde L; Beeler JA; Audet S; Santos-Preciado JI; Gans H; Lew-Yasukawa L; Maldonado YA; Arvin AM; Valdespino-Gómez JL Vaccine; 2006 Jan; 24(5):683-90. PubMed ID: 16154241 [TBL] [Abstract][Full Text] [Related]
16. Population immunity to measles in the United States, 1999. Hutchins SS; Bellini WJ; Coronado V; Jiles R; Wooten K; Deladisma A J Infect Dis; 2004 May; 189 Suppl 1():S91-7. PubMed ID: 15106096 [TBL] [Abstract][Full Text] [Related]
17. Cellular and humoral immune responses to measles in immune adults re-immunized with measles vaccine. Wong-Chew RM; Beeler JA; Audet S; Santos JI J Med Virol; 2003 Jun; 70(2):276-80. PubMed ID: 12696117 [TBL] [Abstract][Full Text] [Related]
18. Intranasal administration of a proteosome-influenza vaccine is well-tolerated and induces serum and nasal secretion influenza antibodies in healthy human subjects. Treanor J; Nolan C; O'Brien D; Burt D; Lowell G; Linden J; Fries L Vaccine; 2006 Jan; 24(3):254-62. PubMed ID: 16129526 [TBL] [Abstract][Full Text] [Related]
19. Humoral and cell-mediated immune responses to an early 2-dose measles vaccination regimen in the United States. Gans HA; Yasukawa LL; Alderson A; Rinki M; DeHovitz R; Beeler J; Audet S; Maldonado Y; Arvin AM J Infect Dis; 2004 Jul; 190(1):83-90. PubMed ID: 15195246 [TBL] [Abstract][Full Text] [Related]
20. Measles antibodies in nasal secretions and sera of children with measles. Polna I; Aleksandrowicz J; Krawczyński K; Krotochwil-Skrzypek M; Rozskowska K Acta Virol; 1977 Jul; 21(4):331-7. PubMed ID: 20768 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]